Researchers discover possible biomarker and therapeutic target for melanoma

Researchers at Boston University School of Medicine (BUSM), in collaboration with Johns Hopkins University, have identified a potential new biomarker and therapeutic target for melanoma. The novel cell screening method used in the study also clarifies the process behind tumour metastasis and may allow the identification of biomarkers for other aggressive cancers. The findings now appear online in Cancer Research...

Read the whole article on

More from